Shaker A. Mousa

Subjects

Therapeutic use, Anticoagulants, Anticoagulants (Medicine), Blood platelets, Drug therapy, Fibrinolytic agents, Heparin, Methods, Physiology, Platelet Aggregation Inhibitors, Thrombocytopenia, Thrombolytic therapy, Cell Adhesion Molecules, Cell adhesion molecules, Extracellular Matrix Proteins, Extracellular matrix proteins, Pathophysiology, Physiological effect, Angiogenesis Inhibitors, Angiography, Aspect social, Blood coagulation disorders, Blood-vessels, Cellular signal transduction, Chinese